Feb 08, 2013 07:30 CET On February 12th 2013, the 7th annual Swiss-Scandinavian Bio-Business Seminar is being held in Zürich, Switzerland. The conference offers a unique possibility to meet Stockholm-based life sciences companies on the cutting edge. Participants include: Aberabio, Binarybio, Biolamia, Biovica, Irras, Oss-Q and Xbrane Bioscience.
Dec 09, 2012 13:48 CET Albeit in spirit, Alfred Nobel and the prize have contributed to Stockholm and Sweden’s position as one of the most innovative regions worldwide. Such diverse inventions as the refrigerator and the mobile phone have their origin in Stockholm. Contemporary household name successes include Skype, Minecraft and Spotify.
Sep 07, 2012 15:19 CEST On September 27th 2012, the fifth annual Stockholm Cleantech Venture Day is being held in Stockholm, Sweden. The conference offers a unique possibility for investors, experts and media to meet northern Europe’s most innovative and promising cleantech companies. Theme for this year is water and energy.
Feb 16, 2013 10:16 CET A positive momentum and large international interest means hectic year for promoters of the Stockholm cleantech sector.
Feb 14, 2013 10:30 CET Boasting excellent infrastructure and a strategically important location, Stockholm is perfectly suited for deliveries to Scandinavia and the Baltic region. And with changes under way, opportunities for international companies are opening up.
Feb 13, 2013 10:30 CET Stockholm-Uppsala, Scandinavia’s leading life-science cluster, is getting increasing attention from international investors as the region's life science sector continues to go from strength to strength.
May 30, 2011 14:50 CEST
May 30, 2011 14:46 CEST
Apr 23, 2013 16:25 CEST Understanding the demands and expectations from people moving to Stockholm is of great importance to continue develop the city as an attractive place to work and live. As a result of a workshop in March 2013 with 50 expats in Stockholm, as SWOT analysis was developed. Included as a benchmark is a SWOT based on a workshop with representatives from local organizations, held in December 2012.
Dec 14, 2011 10:33 CET The US continues to dominate; most venture capital goes to drug discovery platforms and the most successful companies in need of venture capital are those who most clearly fit in to investors' strategy. Despite a leading R&D position, Swedish life science companies must improve international relations to succeed in attracting investments. This emerged in a new report on corporate venture capital.